The hydroxychloroquine–interferon gamma release assay question: TB or not TB? - 14/03/19
Doi : 10.1016/j.jaad.2019.01.070
Warren R. Heymann, MD ⁎ 
Division of Dermatology, Cooper Medical School of Rowan University, Marlton, New Jersey
∗Correspondence to: Warren R. Heymann, MD, Division of Dermatology, Cooper Medical School of Rowan University, 100 Brick Rd, Suite 306, Marlton, New Jersey 08053.Division of DermatologyCooper Medical School of Rowan University100 Brick Rd, Suite 306MarltonNew Jersey08053
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Il testo completo di questo articolo è disponibile in PDF.
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the author. |
© 2019
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 80 - N° 4
P. 902-903 - aprile 2019 Ritorno al numero
Articolo precedente
- Responding to reviewers: Advice to young (and some older) authors
- Dirk M. Elston
- Association between atopic dermatitis and extracutaneous bacterial and mycobacterial infections: A systematic review and meta-analysis
- Linda Serrano, Kevin R. Patel, Jonathan I. Silverberg
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.